Skip to main content

Patient Adherence clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence

    Sorry, in progress, not accepting new patients

    This study evaluates the ability of digital medicines, Proteus Discover, to promote adherence and thus achieving a cure for hepatitis C in patients at high risk for not adhering to their hepatitis therapy. In this single-arm, prospective study, subjects at high risk for nonadherence will be prescribed hepatitis C therapy that will be co-encapsulated with ingestible sensors (creating the digital medicine) by a pharmacy. Both the subject and the providers will have access to the ingestion adherence.

    San Francisco, California and other locations

Last updated: